Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence [PDF]
Background: Varenicline is a smoking cessation medication. Objectives: We analyzed patients’ out-of-pocket costs and utilization of and persistence with varenicline. Methods: De-identified claims data in the MarketScan® Commercial Claims and Encounters Database were analyzed retrospectively.
Aaron Galaznik +5 more
openaire +3 more sources
Households' out‐of‐pocket expenditure for healthcare in Bangladesh: A health financing incidence analysis [PDF]
Background: Despite improvements in many health indicators, providing access to affordable healthcare remains a considerable challenge in Bangladesh. Financing incidence analysis will enable an evaluation of how well the healthcare system performs to ...
Khorshed Alam +19 more
core +1 more source
Out-of-Pocket Expenditures of Myocardial Infarction Patients in Pondicherry, South India [PDF]
Background: Myocardial infarction (MI) is a leading cause of morbidity and mortality worldwide. In India, incidence of MI is rapidly increasing due to lifestyle changes, ageing and rising healthcare costs. The out-of-pocket expenditure (OOPE) for MI care
Chandar Sahanaa +4 more
doaj
The out of pocket cost of breast cancer survivors: a review [PDF]
Out of pocket (OOP) costs add to the burden facing breast cancer survivors but remain an understudied area of costs. Current turbulent economic climate increases the urgency to better understand this burden. Few studies or systematic reviews focus on OOP costs.PubMed search was conducted for articles in English containing: (1) MESH terms breast ...
Maria, Pisu +5 more
openaire +2 more sources
Chronic disease costs from a patient’s perspective: A survey of patients with stroke, heart disease, and chronic kidney disease visiting a district hospital in Indonesia [PDF]
Context: Chronic disease treatment can lead to catastrophic costs. Although most direct medical costs are covered by the National Health Insurance, direct nonmedical and indirect costs may be burdensome for patients.
Dwi Endarti +5 more
doaj +1 more source
Background Although tuberculosis (TB) care is free in Tanzania, TB-associated costs may compromise access to services and treatment adherence resulting in poor outcomes and increased risk of transmission in the community.
Andrew Martin Kilale +17 more
doaj +1 more source
Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure
Background Sacubitril/valsartan improves health outcomes for heart failure with reduced ejection fraction relative to angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers, but it carries higher out‐of‐pocket costs. Neither the impact
Birju R. Rao +11 more
doaj +1 more source
Patient-Physician Communication About Out-of-Pocket Costs [PDF]
Out-of-pocket costs account for approximately one fifth of health care expenditures and are increasing. Previous research suggests that these costs are associated with medication nonadherence and considerable economic burden among some patients. Little is known about patient-physician communication regarding these costs.To identify patients' and ...
G Caleb, Alexander +2 more
openaire +2 more sources
Out-of-pocket (OOP) costs may constitute a substantial financial burden to patients diagnosed with cancer. Earlier stage diagnosis and treatment of cancers may promote decreased morbidity and mortality, subsequently also lowering costs.
Ela Fadli (6874868) +3 more
core +1 more source
AbstractBackgroundOut‐of‐pocket costs (OOPC) associated with treatment have significant implications on quality of life and survival in cancer patients. Head and neck cancer patients face unique treatment‐related challenges, but to date OOPC have been understudied in this population.AimsThis study aims to identify and measure OOPC for patients with ...
Mohemmed N. Khan +15 more
openaire +5 more sources

